Fundraising Fox
Find your path to Petr
10 people in our graph can introduce you to Petr.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Leonid Bakulev to introduce you to Petr
You →Leonid · together at Unicorn Capital Partners (2020–2023) →Petr
Ask Jamie Chen to introduce you to Petr
You →Jamie · together at Saint Petersburg State Medical University →Petr
Ask Sam Okafor to introduce you to Petr
You →Sam · together at Unicorn Capital Partners →Petr
Sign up to find every way you can get introduced to Petr
- Your email: the people you already email who know Petr
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Petr
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Petr Denisov is a Medical Monitor at Confidence Pharmaceutical Research with a decade of experience in drug development strategy and scientific due diligence. He previously served as scientific lead at two biomedical venture capital funds, where he evaluated over 100 opportunities across therapeutic modalities and held board positions at TransMedics and enGene, both NASDAQ-listed companies. Denisov holds an MD and PhD and currently advises early-stage biotech founders and biomedical investors from Israel, working with clients in the US and EU.
Experience
- Confidence Pharmaceutical ResearchMedical Monitorcurrent2023 — presentIsrael
- Confidence Pharmaceutical ResearchFeasibility Managercurrent2023 — presentIsrael
- Unicorn Capital PartnersPartner2019 — 2024Moscow, Russian Federation
- Engene IncBoard Observer2017 — 2020Montreal, Quebec, Canada
- Pharmstandard Ventures (ex Inbio Ventures)Head of Scientific Analysis2014 — 2020Moscow, Russian Federation
- TransMedics, Inc.Member Board Of Directors2019Greater Boston Area
- Synergy Research Group (SynRG)Director, Business Development2013 — 2014St Petersburg, St Petersburg City, Russia
- Worldwide Clinical TrialsAssociate Director, Feasibility2006 — 2013Saint Petersburg, Russian Federation
- different institutionsdifferent positions1999 — 2006Saint Petersburg, Russian Federation
Skills & more
+12 more
Due DiligenceClinical TrialsProtocolClinical MonitoringICH-GCPGCPTherapeutic AreasClinical DevelopmentCTMSScientific Due DiligenceTarget Product Profile (TPP)Investment Due DiligenceLanguages English · Hebrew · Russian
- U.S. Health Law Fundamentals — University of Pennsylvania
- Understanding Clinical Research: Behind the Statistics — University of Cape Town
- Design and Interpretation of Clinical Trials — The Johns Hopkins University
- GOOD CLINICAL PRACTICES — The National Institute on Drug Abuse (NIDA)
- Fundamentals of Clinical Trials — edX
- Financial Markets — Yale University
- Corporate Finance Essentials — IESE Business School
From Petr's professional profile.
Frequently asked questions
- Who is Petr Denisov?
- Petr Denisov is a Medical Monitor at Confidence Pharmaceutical Research with a decade of experience in drug development strategy and scientific due diligence. He previously served as scientific lead at two biomedical venture capital funds, where he evaluated over 100 opportunities across therapeutic modalities and held board positions at TransMedics and enGene, both NASDAQ-listed companies. Denisov holds an MD and PhD and currently advises early-stage biotech founders and biomedical investors from Israel, working with clients in the US and EU.
- Where did Petr Denisov go to school?
- Petr Denisov studied at Saint Petersburg State Medical University (Doctor of Medicine (MD), General Practice); Institute of Experimental Medicine under RAMS (Doctor of Philosophy (PhD), normal physiology); IMISP (Project Management).
